Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.6T | 2.6T | 2.5T | 2.3T |
Cost of revenue | 2.0T | 2.1T | 1.9T | 1.8T |
Gross profit | 507.0B | 523.9B | 532.4B | 503.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 227.2B | 153.7B | 208.9B | 223.9B |
Other operating expenses | 13.7B | 19.6B | 17.5B | 13.3B |
Operating income | 57.5B | 149.3B | 121.6B | 89.4B |
Non operating interest income | ||||
Income | 6.2B | 6.5B | 6.5B | 6.6B |
Expense | 521M | 297M | 458M | 602M |
Other income expense | — | — | — | — |
Pretax income | 62.7B | 160.2B | 128.3B | 89.9B |
Tax provision | 10.9B | 13.6B | 36.6B | 27.8B |
Net income | 51.8B | 146.6B | 91.8B | 62.2B |
Basic EPS | 5 | — | — | — |
Diluted EPS | 5 | — | — | — |
Basic average shares | 9.5B | — | — | — |
Diluted average shares | 9.5B | — | — | — |
EBITDA | 82.8B | 172.8B | 147.7B | 110.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | -140M | 167M | -536M | -1.7B |
Preferred stock dividends | 0 | 0 | 0 | 0 |